Tumor lysis syndrome causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 30: | Line 30: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 38: | Line 38: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 50: | Line 50: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 74: | Line 74: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 90: | Line 90: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Overdose/Toxicity''' | | '''Overdose/Toxicity''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 102: | Line 102: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Renal/Electrolyte''' | | '''Renal/Electrolyte''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 129: | Line 129: | ||
{{col-begin|width=80%}} | {{col-begin|width=80%}} | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[ | *[[Acute lymphoblastic leukemia ]] | ||
* | *[[Acute myeloid leukemia]] | ||
*[[ | *[[Adult T-cell leukemia ]] | ||
*[[ | *[[Adult T-cell lymphoma]] | ||
*[[ | *[[Anaplastic large cell lymphoma]] | ||
*[[ | *[[B-cell ALL]] | ||
*[[ | *[[Bortezomib]] | ||
*[[ | *[[Bortezomib]] | ||
*[[ | *[[Breast cancer ]] | ||
*[[ | *[[Burkitt lymphoma]] | ||
*[[ | *[[Chronic myeloid leukemia]] | ||
*[[ | *[[Cytotoxic chemotherapy]] | ||
*[[ | *[[Diffuse large B-cell lymphoma]] | ||
*[[ | *[[Etoposide]] | ||
*[[ | *[[Fludarabine]] | ||
*[[Gastrointestinal stromal tumors]] | |||
{{col-break|width=33%}} | |||
*[[Germ cell tumors ]] | |||
*[[Glucocorticoids]] | |||
*[[Hepatoblastoma]] | |||
*[[Hepatocellular carcinoma]] | |||
*[[Hodgkin's disease]] | |||
*[[Hydroxyurea]] | |||
*[[Imatinib]] | |||
*[[Isolated plasmacytomas]] | |||
*[[Lenalidomide ]] | |||
*[[Mantle cell lymphoma]] | |||
*[[Medulloblastoma]] | |||
*[[Melanoma]] | |||
*[[Metastatic colorectal cancer ]] | |||
*[[Multiple myeloma]] | |||
*[[Neuroblastoma]] | |||
{{col-break|width=33%}} | |||
*[[Non-hodgkin lymphomas]] | |||
*[[Ovarian cancer ]] | |||
*[[Paclitaxel]] | |||
*[[Radiation therapy ]] | |||
*[[Rhabdomyosarcoma]] | |||
*[[Rituximab]] | |||
*[[Sarcoma]] | |||
*[[Small cell lung cancer]] | |||
*[[Squamous cell carcinoma of the vulva]] | |||
*[[T-cell ALL]] | |||
*[[Thalidomide]] | |||
*[[Transformed lymphoma]] | |||
*[[Urothelial cancer ]] | |||
*[[Zoledronic acid]] | |||
{{col-end}} | {{col-end}} | ||
==References== | ==References== |
Revision as of 00:03, 5 February 2014
Tumor lysis syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tumor lysis syndrome causes On the Web |
American Roentgen Ray Society Images of Tumor lysis syndrome causes |
Risk calculators and risk factors for Tumor lysis syndrome causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The most common tumors associated with this syndrome are poorly differentiated lymphomas, such as Burkitt's lymphoma, and leukemias, such as acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Other cancers have also been associated with TLS but are less common. Usually, the precipitating medication regimen includes combination chemotherapy, but those patients with lymphoma and ALL can be affected with steroid treatment alone.
Causes
Life Threatening Causes
Common Causes
Causes by Organ System
Cardiovascular | No underlying causes |
Chemical/Poisoning | No underlying causes |
Dental | No underlying causes |
Dermatologic | No underlying causes |
Drug Side Effect | |
Ear Nose Throat | No underlying causes |
Endocrine | |
Environmental | No underlying causes |
Gastroenterologic | No underlying causes |
Genetic | |
Hematologic | No underlying causes |
Iatrogenic | No underlying causes |
Infectious Disease | No underlying causes |
Musculoskeletal/Orthopedic | No underlying causes |
Neurologic | No underlying causes |
Nutritional/Metabolic | |
Obstetric/Gynecologic | |
Oncologic | No underlying causes |
Ophthalmologic | No underlying causes |
Overdose/Toxicity | |
Psychiatric | No underlying causes |
Pulmonary | No underlying causes |
Renal/Electrolyte | |
Rheumatology/Immunology/Allergy | |
Sexual | No underlying causes |
Trauma | No underlying causes |
Urologic | No underlying causes |
Miscellaneous | No underlying causes |